Samuel J Reich
CIK 1394645 · CEO · last filed 2026-02-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.7K
Companies
3
Total Filings
14
Lifetime Open-Market Net
$4.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SABSW | CEO | 766,699 | $0.01 | $9.7K | $9.8K | 11 | 2026-02-05 |
| SAB Biotherapeutics, Inc. (BCYPW) Delisted | CEO and CFO | 3,048,825 | $1.10 | $3.35M | $10.1K | 1 | 2021-10-15 |
| SAB Biotherapeutics, Inc. (BCYPU) Delisted | CEO and CFO | 3,047,825 | $8.57 | $26.12M | $4.17M | 1 | 2021-01-14 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-19 | SABSW | Grant (A) | — | $0 | EDGAR |
| 2021-10-15 | SAB Biotherapeutics, Inc. (BCYPW) Delisted | Buy (P) | +1,000 | $10.1K | EDGAR |
| 2021-01-14 | SAB Biotherapeutics, Inc. (BCYPU) Delisted | Buy (P) | +417,200 | $4.17M | EDGAR |
| 2007-04-02 | — | Other (J) | +490,921 | $0 |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.